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∗ Tel.: +81 3 3972 8111x2442; fax: +81 3 3957 6186.Surgical incision was thought to completely eliminate conduc-
ion by creating a surgical scar along the incision line. The surgical
reatment of accessory atrioventricular pathways used to be per-
ormed in symptomatic supraventricular tachycardia patients [1,2].
he acute success rate of these reports was favorable.
Cox/maze procedure was also effective for drug refractory atrial
brillation. However, it became more popular to use radiofre-
uency energy [3] or cryosurgery instead of cut and saw procedure
4–7] probably because of the wideness and completeness of
urgery scar.
Atrio-atrial conduction following cardiac transplantation has
lready been reported in cardiac transplantation patients [8–10].
he possible mechanism of this phenomenon is a bridge of excitable
yocardium growing across the atrio-atrial anastomosis, allowing
irect conduction of cardiac action potentials [9].
The  present paper by Law et al. was a patient with atrioventric-
lar reentrant tachycardia using retrograde ventriculo-atrial (VA)
onduction 6 years after Bjork palliation. Before palliation, there
as no antegrade atrial-ventricular conduction and this patient had
o episode of supraventricular tachycardia before Bjork surgery.
hey conﬁrmed the shortest VA conduction at the mouth of right
trial appendage where the anastomosis was carried out to the right
entricular outﬂow tract. They successfully eliminated VA conduc-
ion at that site. From this report and previous reports [11–16], we
ealize that surgical incision scar is not a complete obstacle to con-
uction but could be a neo tissue conduction and could be a new
rrhythmogenic focus.
From  these results, we have to take care of the gap that might be
resent or the neo atrio-atrial conduction that might exist along the
ine of surgical incision. Part of the reason of difﬁculty in catheter
blation for atrial tachycardia in complicated atrial surgery, such
s Mustard or Senning procedure, may  be due to the gap or neo
trio-atrial conduction along the line of incision.
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